Drugs Made In America Acquisition (DMAAR) Income from Continuing Operations (2025)
Drugs Made In America Acquisition (DMAAR) posted Income from Continuing Operations of 212958.0 for Q4 2025, down 90.25% on a QoQ basis from 2184563.0 in Q3 2025.
Drugs Made In America Acquisition (DMAAR) Income from Continuing Operations (2025) Analysis & Trends
Drugs Made In America Acquisition's Income from Continuing Operations history runs 1 years deep, the most recent figure standing at 212958.0 for Q4 2025.
- Quarterly Income from Continuing Operations changed N/A year-over-year to 212958.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5940643.0 (changed N/A YoY) and the FY2025 annual result came in at 5940643.0, up 2222.83% from the prior year.
- Income from Continuing Operations was 212958.0 for Q4 2025 at Drugs Made In America Acquisition, down from 2184563.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2288579.0 in Q2 2025 and bottomed at 212958.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 2.03 Mn |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | -394,142.00 |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | 1.38 Mn |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - | -728,564.00 |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | - |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | - |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | 1.88 Mn |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - | 2.05 Mn |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - | 1.87 Mn |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - | 212,958.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 212,958.00 |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 1.25 Mn |